3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gynecologic
1
Conditions
Thyroid Nodule
4
Prostatic Neoplasms
4
Thyroid Cancer, Papillary
3
Uterine Cervical Neoplasms
2
Papillomavirus Infections
2
Uterine Neoplasms
1
Uterine Diseases
1
Uterine Cervical Dysplasia
1
Uterine Cervical Diseases
1
Urogenital Neoplasms
1
Urogenital Diseases
1
Thyroid Neoplasms
1
Recurrence
1
Prostatic Hyperplasia
1
Precancerous Conditions
1
Neoplasms by Site
1
Neoplasms
1
HIV Infections
1
Genital Neoplasms, Female
1
Genital Diseases, Female
1
Genital Diseases
1
Female Urogenital Diseases and Pregnancy Complications
1
Depression
1
Carcinoma, Hepatocellular
1
Anxiety Disorders
1
Interventions
Paclitaxel
4
pembrolizumab
3
Cisplatin
3
Doxorubicin
2
Carboplatin
2
Brachytherapy
2
Biopsy
2
trastuzumab deruxtecan
1
sacituzumab govitecan
1
relugolix
1
dostarlimab
1
dehydroftorafur
1
belzutifan
1
Watchful Waiting
1
Vaginal Smears
1
VMBP protocol
1
Ultrasound, High-Intensity Focused, Transrectal
1
Transurethral Resection of Prostate
1
Taxes
1
Sutures
1
Standard of Care
1
Radiotherapy, Intensity-Modulated
1
Pregnancy Tests
1
Practice Guidelines as Topic
1
Platinum
1
Papanicolaou Test
1
Oxaliplatin
1
Mitozytrex
1
Mitomycin
1
Magnetic Resonance Spectroscopy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Uterine Neoplasms
×
Transurethral Resection of Prostate
×
Clear all
NCT06815939
2026-01-29
OPTICS
DL Analytics
Phase NA
Recruiting
10,000 enrolled